Cargando…
Medications that cause weight gain and alternatives in Canada: a narrative review
BACKGROUND: The cause of the obesity epidemic is multifactorial, but may, in part, be related to medication-induced weight gain. While clinicians may strive to do their best to select pharmacotherapy(ies) that has the least negative impact on weight, the literature regarding the weight effects of me...
Autores principales: | Wharton, Sean, Raiber, Lilian, Serodio, Kristin J, Lee, Jasmine, Christensen, Rebecca AG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109660/ https://www.ncbi.nlm.nih.gov/pubmed/30174450 http://dx.doi.org/10.2147/DMSO.S171365 |
Ejemplares similares
-
Weight loss medications in Canada – a new frontier or a repeat of past mistakes?
por: Wharton, Sean, et al.
Publicado: (2017) -
Next Generation of Weight Management Medications: Implications for Diabetes and CVD Risk
por: Wharton, S., et al.
Publicado: (2015) -
Predictors of Weight Loss and Weight Gain in Weight Management Patients during the COVID-19 Pandemic
por: Kuk, Jennifer L., et al.
Publicado: (2021) -
Real‐World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
por: Wharton, Sean, et al.
Publicado: (2019) -
Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real‐world effectiveness study in Canada
por: Wharton, Sean, et al.
Publicado: (2020)